BlackRock Investment Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.73M | Sell |
294,398
-908
| -0.3% | -$5.32K | ﹤0.01% | 2322 |
|
|
2016
Q3 | $1.57M | Sell |
295,306
-770
| -0.3% | -$4.09K | ﹤0.01% | 2350 |
|
|
2016
Q2 | $1.96M | Sell |
296,076
-53,802
| -15% | -$356K | ﹤0.01% | 2117 |
|
|
2016
Q1 | $1.63M | Buy |
349,878
+5,406
| +2% | +$25.2K | ﹤0.01% | 2135 |
|
|
2015
Q4 | $1.74M | Buy |
344,472
+575
| +0.2% | +$2.9K | ﹤0.01% | 2181 |
|
|
2015
Q3 | $1.21M | Sell |
343,897
-5,668
| -2% | -$20K | ﹤0.01% | 2458 |
|
|
2015
Q2 | $3.49M | Buy |
349,565
+69,957
| +25% | +$698K | ﹤0.01% | 1779 |
|
|
2015
Q1 | $3.56M | Buy |
279,608
+30,794
| +12% | +$392K | ﹤0.01% | 1631 |
|
|
2014
Q4 | $3.52M | Sell |
248,814
-1,441
| -0.6% | -$20.4K | ﹤0.01% | 1630 |
|
|
2014
Q3 | $3.44M | Buy |
250,255
+125
| +0% | +$1.72K | ﹤0.01% | 1603 |
|
|
2014
Q2 | $3.85M | Buy |
250,130
+4,001
| +2% | +$61.5K | 0.01% | 1579 |
|
|
2014
Q1 | $4.19M | Buy |
246,129
+21,520
| +10% | +$367K | 0.01% | 1487 |
|
|
2013
Q4 | $2.91M | Sell |
224,609
-6,163
| -3% | -$79.8K | ﹤0.01% | 1734 |
|
|
2013
Q3 | $2.33M | Buy |
230,772
+12,419
| +6% | +$125K | ﹤0.01% | 1842 |
|
|
2013
Q2 | $1.63M | Buy |
+218,353
| New | +$1.63M | ﹤0.01% | 2009 |
|